0001144204-17-002903.txt : 20170119 0001144204-17-002903.hdr.sgml : 20170119 20170119154402 ACCESSION NUMBER: 0001144204-17-002903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170117 FILED AS OF DATE: 20170119 DATE AS OF CHANGE: 20170119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG MICHAEL M CENTRAL INDEX KEY: 0000905011 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 17535907 MAIL ADDRESS: STREET 1: C/O MONTAUR CAPITAL PARTNERS STREET 2: 152 WEST 57TH STREET, 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 v457179_4.xml OWNERSHIP DOCUMENT X0306 4 2017-01-17 0 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0000905011 GOLDBERG MICHAEL M 5600 BLAZER PARKWAY, SUITE 200 DUBLIN OH 43017 1 1 0 0 President & CEO NAVB Common Stock, $.001 par value 2017-01-17 4 X 0 5411850 0.01 A 5815002 D Warrants (Right to Buy) 0.01 2017-01-17 4 X 0 5411850 0.00 D 2016-10-17 2035-08-20 Common Stock 5411850 0 D Series LL warrants exercised in exchange for issuance of common stock. /s/ Michael M. Goldberg 2017-01-19